Involvement of interleukin-1β, nerve growth factor and prostaglandin E2 in endotoxin-induced localized inflammatory hyperalgesia

British Journal of Pharmacology

Volumn 121, Issue 8, 1997, Pages 1619-1626

  Safieh Garabedian, Bared ^a   Kanaan, Salim A ^a   Haddad, John J ^a   Jaoude, Pamela Abou ^a   Jabbur, Suhayl J ^a   Saadé, Nayef E ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Hyperalgesia; Inflammation; Interleukin 1 ; Nerve growth factor; Prostaglandin E2

Indexed keywords

DEXAMETHASONE; ENDOTOXIN; INDOMETACIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR ANTIBODY; PROSTAGLANDIN E2; TRIPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ETIOLOGY; HOT PLATE TEST; HYPERALGESIA; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

ANIMALS; DEXAMETHASONE; DINOPROSTONE; ENDOTOXINS; HYPERALGESIA; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; NERVE GROWTH FACTORS; RATS; RATS, SPRAGUE-DAWLEY; SIALOGLYCOPROTEINS;

EID: 0030822876     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701313     Document Type: Article

References (34)

1. ANDREEV, N.Y., DIMITRIEVA, N., KOLTZENBURG, M. & MCMAHON, S.B. (1995). Peripheral administration of nerve growth factor in the adult rat produces thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurones. Pain, 63, 109-115.
2. BENEDETTI, C. & BUTLER, S.H. (1990). Systemic analgesics. In Management of Pain, ed. Bonica J.J. pp. 1640-1675, Philadelphia: Lea and Febiger.
3. BROCHARD, R.E., BARNES, C.D. & ELTHERINGTON, L.G. (1992). Drug Dosage in Laboratory Animals. A handbood, 3rd edition, Florida: Boca Raton.
4. CUNHA, F.Q., POOLE, S., LORENZETTI, B.B. & FERREIRA, S.H. (1992). The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia. Br. J. Pharmacol., 107, 660-664.
5. DAWSON, J., RORDORF-ADAM, C., GEIGER, T., TOWBIN, H., KUNZ, S., NGUYEN, H. & ZINGEL, O. (1993). Interleukin-1 (IL-1) production in a mouse tissue chamber model of inflammation. II. Identification of (tissue) macrophages as the IL-1 producing cells and the effect of anti-inflammatory drugs. Agents Actions, 38, 255-264.
6. DONNERER, J., SCHULIGOI, R. & STEIN, C. (1992). Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflammed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience, 49, 693-698.
7. DRAY, A. (1995). Inflammatory mediators of pain. Br. J. Anaesthesiol., 75, 125-131.
8. FERREIRA, S.H., LORENZETTI, B.B., BRISTOW, A.F. & POOLE, S. (1988). Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature, 334, 698-700.
9. FERREIRA, S.H., LORENZETTI, B.B. & POOLE, S. (1993). Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br. J. Pharmacol., 110, 1227-1231.
10. FOLLENFANT, R.L., NAKAMURA-CRAIG, M., HENDERSON, B. & HIGGS, G.A. (1989). Inhibition by neuropeptides of interleukin-1β induced, prostaglandin-independent hyperalgesia. Br. J. Pharmacol., 98, 41-43.
11. FUKUOKA, H., KAWATANI, M., KISAMITSU, R. & TAKESHIGE, C. (1994). Cutaneous hyperalgesia induced by peripheral injection of interleukin-1β in the rat. Brain Res., 657, 374-382.
12. JABBUR, S.J., KANAAN, S.A., SAFIEH-GARABEDIAN, B., ATWEH, S.F. & SAADÉ, N.E. (1996). Effects of various drugs on endotoxin (ET)-induced hyperalgesia in rodents. Soc. Neurosci. Abstr., 22, p1812.
13. KANAAN, S., SAADÉ, N.E., HADDAD, J.J., ABDELNOOR, A.M., ATWEH, S.F., JABBUR, S.J. & SAFIEH-GARABEDIAN, B. (1996). Endotoxin-induced local inflammation and hyperalgesia in rats and mice: A new model for inflammatory pain. Pain, 66, 373-379.
14. LEE, S.H., SOYOOLA, E., CHAMUGAN, P., HART, S., SUN, W., ZHONG, H., LIOU, S., SIMMONS, D. & HWANG, D. (1992). Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem., 267, 25934-25938.
15. LEE, S.W., TSOU, A.P., CHAN, H., THOMAS, J., PETRIE, K., EUGUI, E.M. & ALLISON, A.C. (1988). Glucocorticoids selectivity inhibit the transcription of the interleukin 1 beta and decrease the stability of interleukin 1 beta mRNA. Proc. Natl. Acad. Sci. U.S.A., 85, 1204-1208.
16. LEWIN, G.R., RITTER, A.M. & MENDELL, L.M. (1993). Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J. Neurosci., 13, 2136-2148.
17. LINDHOLM, D., NEUMANN, R., MEYER, M. & THOENEN, H. (1987). Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature, 330, 658-659.
18. LINDSAY, R.M., LOCKETT, C., STERNBERG, J. & WINTER, J. (1989). Neuropeptide expression in cultures of adult sensory neurones: modulation of substance P and calcitonin gene-related peptide levels by nerve growth factor. Neuroscience, 33, 53-65.
19. MAIER, J.A.M., HLAS, T. & MACIAG, T. (1990). Cyclooxygenase is an immediate early gene induced by interleukin-1 in human endothelial cells. J. Biol. Chem., 265, 10805-10808.
20. MASFERRER, J.Z., SEIBERT, K., ZWEIFEL, B. & NEEDLEMAN, P. (1992). Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc. Natl. Acad. Sci. U.S.A., 89, 3917-3921.
21. MCMAHON, S.B., LEWIN, G.R. & WALL, P.D. (1993). Central hyperexcitability triggered by noxious inputs. Curr. Opionions Neurohiol., 3, 602-610.
22. MITCHELL, J.A., AKARASEREENNONT, P., THEMERMANN, C., FLOWER, R.J. & VANE, J.R. (1993). Selectivity of non steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cycloxygenase. Proc. Natl. Acad. Sci. U.S.A., 90, 11693-11697.
23. 193 195. Br. J. Pharmacol., 106, 489-492.
24. REEH, P.W. (1994). Chemical excitation and sensitization of nociceptors. In Cellular Mechanisms of Sensory Processing. ed. Urban, L. pp. 119-270, Berlin, Heidelberg: Springer-Verlag.
25. SAFIEH-GARABEDIAN B., POOLE, S., ALLCHORNE, A., WINTER, J., WOOLF, C.J. (1995). Contribution of interleukin-1β to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br. J. Pharmacol., 115, 1265-1275.
26. TAKTAK, Y.S., SELKIRK, S., BRISTOW, A.F., CARPENTER, A., BALL, C., RAFFERTY, B. & POOLE, S. (1991). Assay of pyrogens by interleukin-6 release from monocyte cell lines. J. Pharm. Pharmacol., 43, 578-582.
27. UTSUNOMIYA, I., NAGAI, S. & OH-ISHI, S. (1994). Differential effects of indomethacin and dexamethasone on cytokine production in carrageenin-induced rat pleurisy. Eur. J. Pharmacol., 252, 213-218.
28. VICTOROV, A.V. & HOEK, J.B. (1995). Secretion of prostaglandins elicited by lipopolysaccharide and ethanol in cultured rat Kupffer cells. Biochem. Biophys. Res. Commun., 215, 691-697.
29. WATKINS, L.R., MAIER, S.F. & GOEHLER, L.E. (1995). Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain, 63, 289-302.
30. WATKINS, L.R., WIERTELAK, E.P., GOEHLER, L., SMITH, K.P., MARTIN, D. & MAIER, S.F. (1994). Characterisation of cytokine-induced hyperalgesia. Brain Res., 654, 15-26.
31. WESKAMP, G. & OTTEN, U. (1987). An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues. J. Neurochem., 48, 1779-1786.
32. WOOLF, C.J. (1996). Phenotypic modifications of primary sensory neurones: the role of nerve growth factor in the production of persistent pain. Phil. Trans. R. Soc. Lond. B., 351, 441-448.
33. WOOLF, C.J., SAFIEH-GARABEDIAN, B., MA, Q.-P., CRILLY, P. & WINTER, J. (1994). Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience, 62, 327-331.
34. ZIMMERMAN, M. (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain, 16, 109-110.